Similarly, TLR9 overexpression has been associated with increased inflammatory responses and poor prognosis in various cancers, including glioblastoma, prostate carcinoma, breast cancer, ovarian cancer, colorectal carcinoma, and HCC [23, 69, 93, 179, 189, 194, 303]. This evidence concerns the gene TLR9 and cancer.